Status:
UNKNOWN
Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis
Lead Sponsor:
Spartanburg Regional Healthcare System
Conditions:
Eczema
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
This study is being done to see in B12 applied to the skin will improve the symptoms of eczema in children compared to a placebo creme
Detailed Description
INTRODUCTION: Atopic dermatitis is a prevalent disease process in children, affecting up to 20% of children in the United States. Various treatment options are available to treat atopic dermatitis to ...
Eligibility Criteria
Inclusion
- children presenting to the Center for Family Medicine or Regional Pediatrics between the ages of 6 months and 18 years old with atopic dermatitis
Exclusion
- unwillingness of parent to consent to study protocol, pregnancy or lactation, eczema with superinfection present, known history of allergy to Vitamin B12 or components of the base cream, topical treatment with corticosteroids in the 4 weeks prior to enrollment
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00465699
Start Date
April 1 2007
End Date
April 1 2007
Last Update
April 25 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Family Medicine
Spartanburg, South Carolina, United States, 29303